ALZN-002

N/A

Report date: 2024/12/18 10:39:21

Base Information

Drug NameALZN-002

Drug Alias NameALZN-002AL-002 (Alzamend Neuro)CAO-22WE22-WE22-W42

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionDendritic cells stimulants

TargetsNot applicable

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesAlzamend Neuro Inc

China Registration ClassN/A

Develop Information

Active CompaniesAlzamend Neuro Inc

Inactive CompaniesN/A

Active IndicationsAlzheimer Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A